Use Of 3-Substituted-2-(Diphenylmethy)-1-Azabicyclo[2.2.2]Octanes For Treating Mrg-X1 Receptor Mediated Diseases
申请人:Kunapuli Priya
公开号:US20080027095A1
公开(公告)日:2008-01-31
The invention encompasses a method for treating a disease or condition mediated by the human MRG-X1 receptor, such as nociception, hyperalgesia, allodynia, pain related to central hypersensitivity conditions, somatic pain, visceral pain, acute pain, chronic pain, post-operative pain, headache, inflammatory pain, neurological pain, musculoskeletal pain, cancer related pain or vascular pain, in a human patient in need thereof comprising administering to the patient a therapeutically effective amount of a 3-substituted-2-(diphenylmethy)-1-azabicyclo[2.2.2]octane or a pharmaceutically acceptable salt thereof. The invention is also directed to the use of these compounds as molecular tools to directly explore the role of the MRG-X1 receptor in pain perception.
METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS
申请人:Dong Xinzhong
公开号:US20120073001A1
公开(公告)日:2012-03-22
The invention features therapeutic compositions comprising agents useful for the treatment or prevention of pruritis, and methods useful for identifying such agents.
US9771592B2
申请人:——
公开号:US9771592B2
公开(公告)日:2017-09-26
Hansch analysis of veratric acid derivatives as antimicrobial agents
The synthesis, characterization and antimicrobialevaluation of a new series of veratric acid derivatives are presented. Preliminary in vitro antimicrobial activity of the title compounds was assessed against a panel of microorganisms including Gram-positive and Gram-negative bacteria and fungi. Some of the veratric acid derivatives exhibited significant in vitro antimicrobial activity. QSAR investigation
A ruthenium-catalyzed oxidative coupling of substituted aromatic and heteroaromatic esters with alkenes in the presence of catalytic amounts of AgSbF6 and Cu(OAc)2 to provide highly substituted alkene derivatives in good to excellent yields under an open atmosphere is described.